Brown Advisory Inc Ginkgo Bioworks Holdings, Inc. Transaction History

Brown Advisory Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.28 - $1.16 $30,591 - $126,738	-109,257 Reduced 46.12%	127,629 $42,000
Q1 2024 Apr 24, 2024	SELL	$1.06 - $1.67 $2,691 - $4,240	-2,539 Reduced 1.06%	236,886 $274,000
Q4 2023 Feb 08, 2024	BUY	$1.26 - $1.79 $44,329 - $62,975	35,182 Added 17.23%	239,425 $404,000
Q3 2023 Oct 24, 2023	SELL	$1.61 - $2.54 $64,892 - $102,377	-40,306 Reduced 16.48%	204,243 $369,000
Q2 2023 Jul 31, 2023	BUY	$1.14 - $1.95 $90,362 - $154,566	79,265 Added 47.96%	244,549 $454,000
Q1 2023 May 08, 2023	BUY	$1.2 - $2.19 $852 - $1,554	710 Added 0.43%	165,284 $219,000
Q4 2022 Feb 13, 2023	BUY	$1.63 - $3.52 $34,776 - $75,099	21,335 Added 14.89%	164,574 $278,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $7,227 - $37,026	9,900 Added 7.42%	143,239 $447,000
Q2 2022 Nov 14, 2022	BUY	$2.2 - $4.2 $194,387 - $371,103	88,358 Added 196.43%	133,339 $317,000
Q2 2022 Aug 02, 2022	BUY	$2.2 - $4.2 $194,387 - $371,103	88,358 Added 199.95%	132,549 $315,000
Q1 2022 Nov 14, 2022	SELL	$2.83 - $8.69 $247,817 - $760,965	-87,568 Reduced 66.06%	44,981 $181,000
Q1 2022 May 09, 2022	BUY	$2.83 - $8.69 $125,060 - $384,019	44,191 New	44,191 $178,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $13.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.